Latest Buy Backs News

European Metals says a single tunnel kiln could cut Cinovec’s capital cost by about US$112 million and operating costs by US$10 million a year, but the savings remain preliminary. The company also has until 13 November to secure EUR6.448 million if it wants to restore its 49% stake in the project vehicle.

DGR Global ended September with A$54.4 million in cash after investing almost A$5 million in Sunstone Metals, while unpaid Savannah royalties and an Armour Energy appeal add uncertainty. The explorer is redirecting its post-SolGold balance sheet towards copper-gold projects in Queensland and Ecuador.

McPherson’s has entered FY27 with first-quarter sales about 11% below the prior corresponding period, after a disappointing FY26 loss and a costly operating transition. The company says EBITDA growth remains achievable, but its transformation now faces a test of execution and leadership change.

CZR Resources has extended gold mineralisation at Croydon, including its strongest Top Camp result to date, while high-grade iron sampling adds momentum across its Pilbara portfolio. But the company’s proposed Zuleika Gold takeover has run into a shareholder approval failure and now requires ASIC consent to be withdrawn.

Silver Mines has entered the final stretch of the Bowdens approval process after reporting a 93.5 million ounce silver reserve, a completed A$26 million royalty consolidation and A$70 million of new funding. The project’s headline 26-year economics remain partly dependent on a Stage 2 design that is not yet at definitive feasibility level.

Nexus Minerals has ended the September quarter with a 631,000oz Wallbrook gold resource, A$7.95 million in cash and a funded drilling program ahead. The company is now moving from resource growth towards processing, permitting and potential mine development, though no Ore Reserve has yet been defined.

DigitalX ended September with $60.7 million in cash, digital assets and investments, no debt and a completed $3.1 million share buy-back. The company is seeking approval for another 120 million-share buy-back while weighing AI and blockchain acquisitions.

Tissue Repair has increased its US Phase III chronic wound trial to approximately 112 randomised patients while shifting focus towards an April 2027 FDA 510(k) submission. The company also reported $4.74 million in cash, Australian availability of all three TR Pro+ formats and a planned $1 million share buy-back.

Turaco Gold has secured firm commitments for a A$120 million placement to fund its proposed acquisition of Afema’s remaining 20% interest and push the Côte d’Ivoire project towards a definitive feasibility study. The transaction would simplify ownership, but still depends on shareholder approval and further development funding.

Locality Planning Energy has completed its PowerHub acquisition and expanded its active service-point base to 38,776, while drawing no funds from a newly available Westpac facility. The growth comes alongside a $1.6 million quarterly operating cash outflow and an on-market buy-back funded from cash flow and reserves.

Challenger has used its 2026 AGM to showcase stronger earnings, record annuity sales and a substantial capital buffer while keeping discussions open with TAL Daiichi Life over its $11.80-per-share approach. The board still does not consider the proposal sufficient to recommend to shareholders.

Alcidion has started FY27 with contracted revenue up 38% to $50.0 million, while a major UK expansion and new patient administration product widen its growth case. The company has also reaffirmed that FY27 revenue and underlying EBITDA will exceed FY26, but its capital plan now has several competing demands.